Clinical Trial: Prediction of Getting Peripheral Neuropathy in Patients Treated With Bortezomib?
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Chemotherapy-induced Peripheral Neuropathy
Study Type: OBSERVATIONAL
Official Title: Neurofilament Light Chain as Biomarker for Bortezomib-induced Peripheral Neuropathy
Brief Summary:
Investigation of which patients treated with bortezomib that have increased risk of developing peripheral neuropathy.
Read more